INCY
Incyte Corporation
NASDAQ · Healthcare · Biotechnology · US
$126.75
−0.98%Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- -0.62x
- Debt / assets
- 0.00x
- Debt / EBITDA
- 0.02x
- Net debt / EBITDA
- -1.93x
Liquidity & coverage
- Current ratio
- 4.66x
- Quick ratio
- 4.58x
- Cash ratio
- 3.46x
- Interest coverage
- 790.59x
- EBITDA / interest
- 878.44x
- Working capital
- $4.8B
Cash & dividend
- FCF / debt
- 50.19x
- Cash flow / debt
- 51.73x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026